Binase and other microbial RNases as potential anticancer agents

, &
Bioessays 30 (8):781-790 (2008)
  Copy   BIBTEX

Abstract

Some RNases possess preferential cytotoxicity against malignant cells. The best known of these RNases, onconase, was isolated from frog oocytes and is in clinical trials as anticancer therapy. Here we propose an alternative platform for anticancer therapy based on T1 RNases of microbial origin, in particular binase from Bacillus intermedius and RNase Sa from Streptomyces aureofaciens. We discuss their advantages and the most promising directions of research for their potential clinical applications. BioEssays 30:781–790, 2008. © 2008 Wiley Periodicals, Inc.

Categories

Keywords

Reprint years

DOI

10.1002/bies.20789

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,503

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

DNA microarrays in the clinic: infectious diseases.Vladimir Mikhailovich, Dmitry Gryadunov, Alexander Kolchinsky, Alexander A. Makarov & Alexander Zasedatelev - 2008 - Bioessays 30 (7):673-682.
If microbial ecosystem therapy can change your life, what's the problem?Grace Ettinger, Jeremy P. Burton & Gregor Reid - 2013 - Bioessays 35 (6):508-512.
Beyond the genome: community-level analysis of the microbial world.Iratxe Zarraonaindia, Daniel P. Smith & Jack A. Gilbert - 2013 - Biology and Philosophy 28 (2):261-282.
Microbial diversity and the “lower-limit” problem of biodiversity.Christophe Malaterre - 2013 - Biology and Philosophy 28 (2):219-239.
Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics.Mark Lyte - 2011 - Bioessays 33 (8):574-581.
The possibility of alternative microbial life on Earth.Carol E. Cleland - unknown
Learning and exploiting context in agents.Bruce Edmonds - manuscript
Adaptation or selection? Old issues and new stakes in the postwar debates over bacterial drug resistance.Angela N. H. Creager - 2007 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 38 (1):159-190.
Towards a processual microbial ontology.Eric Bapteste & John Dupre - 2013 - Biology and Philosophy 28 (2):379-404.
Hitting the target. Molecular aspects of anticancer drug‐DNA interactions, vol. 1 (1993). By S. N EIDLE and M. W ARING. Macmillan. pp. xi+364. £65. ISBN 0‐333‐55115‐X. [REVIEW]Geoff Margison - 1994 - Bioessays 16 (10):780-780.
Relationships between obligations and actions in the context of institutional agents, human agents or software agents.Robert Demolombe - 2011 - Artificial Intelligence and Law 19 (2-3):99-115.

Analytics

Added to PP
2013-11-23

Downloads
8 (#1,309,160)

6 months
3 (#968,143)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references